BR9815899A - Compostos antivirais - Google Patents

Compostos antivirais

Info

Publication number
BR9815899A
BR9815899A BR9815899-6A BR9815899A BR9815899A BR 9815899 A BR9815899 A BR 9815899A BR 9815899 A BR9815899 A BR 9815899A BR 9815899 A BR9815899 A BR 9815899A
Authority
BR
Brazil
Prior art keywords
alkyl
hydrogen
halo
virus
formula
Prior art date
Application number
BR9815899-6A
Other languages
English (en)
Inventor
Jesus Ezquerra-Carrera
Joseph Michael Gruber
Chafiq Hamdouchi Hamdouchi
Richard Elmer Holmes
Wayne Alfred Spitzer
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9815899A publication Critical patent/BR9815899A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: <B>"COMPOSTOS ANTIVIRAIS"<D>. A presente invenção refere-se a compostos de Fórmula (I), que inibem o crescimento de picornavírus, vírus da Hepatite, enterovírus, cardiovírus, poliovírus, coxsakievírus dos grupos A e B, vírus eco e vírus Mengo. Na dita fórmula, - A é fenila, piridila, fenila substituída, piridila substituída ou benzila; - R é hidrogênio, COR^ 4^ ou COCF~ 3~; - X é N-OH, O, ou CHR.; - R. é hidrogênio, halo, CN, C~ 1~-C~ 4~ alquila, -C<154>CH, CO(C~ 1~-C~ 4~ alquila), CO~ 2~(C~ 1~-C~ 4~ alquila) ou CONR²R³; - R² e R³ são independentemente hidrogênio ou C~ 1~-C~ 4~ alquila; - A' é hidrogênio, halo, C~ 1~-C~ 6~ alquila, benzila, naftila, tienila, furila, piridila, pirrolila, COR^ 4^, S(O)nR^ 4^, ou um grupo de fórmula (II): em que: - R^ 4^ é C~ 1~-C~ 6~ alquila, fenila ou fenila substituída; - n é 0, 1 ou 2; - R^ 5^ independentemente em cada ocorrência hidrogênio ou halo; - m é 1, 2, 3, ou 4; e - R^ 6^ é hidrogênio, halo, CF~ 3~, OH, CO~ 2~H, NH~ 2~, NO~ 2~, CONHOCH~ 3~, C~ 1~-C~ 4~ alquila, ou CO~ 2~(C~ 1~-C~ 4~ alquila), C~ 1~-C~ 4~ alcóxi, ou sais farmaceuticamente aceitáveis dos mesmos.
BR9815899-6A 1998-05-20 1998-05-20 Compostos antivirais BR9815899A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1998/010299 WO1999059587A1 (en) 1998-05-20 1998-05-20 Anti-viral compounds

Publications (1)

Publication Number Publication Date
BR9815899A true BR9815899A (pt) 2001-02-20

Family

ID=22267098

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9815899-6A BR9815899A (pt) 1998-05-20 1998-05-20 Compostos antivirais

Country Status (15)

Country Link
EP (1) EP1077701A4 (pt)
JP (1) JP2002515433A (pt)
KR (1) KR20010025055A (pt)
CN (1) CN1292697A (pt)
AU (1) AU7583098A (pt)
BR (1) BR9815899A (pt)
CA (1) CA2332403A1 (pt)
CZ (1) CZ289425B6 (pt)
EA (1) EA200001208A1 (pt)
HU (1) HUP0102117A2 (pt)
IL (1) IL139166A0 (pt)
NO (1) NO20005795L (pt)
SK (1) SK17482000A3 (pt)
TR (1) TR200003414T2 (pt)
WO (1) WO1999059587A1 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR213700A0 (en) 2000-12-18 2001-01-25 Biota Scientific Management Pty Ltd Antiviral agents
AR048650A1 (es) * 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
ATE462697T1 (de) 2004-08-12 2010-04-15 Amgen Inc Bisaryl-sulfonamide
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
WO2006101455A1 (en) * 2005-03-21 2006-09-28 S*Bio Pte Ltd Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications
ES2395386T3 (es) 2005-12-21 2013-02-12 Abbott Laboratories Compuestos antivirales
AU2006330924B2 (en) 2005-12-21 2012-03-15 Abbvie Inc. Anti-viral compounds
DE602006015861D1 (de) 2005-12-21 2010-09-09 Abbott Lab Antivirale verbindungen
TWI399380B (zh) 2006-12-20 2013-06-21 Abbott Lab 抗病毒化合物
CN102046621B (zh) * 2008-05-27 2014-11-12 生物区科学管理控股有限公司 抗病毒盐
JP2012513409A (ja) 2008-12-23 2012-06-14 アボット・ラボラトリーズ 抗ウイルス化合物
CN102245604A (zh) 2008-12-23 2011-11-16 雅培制药有限公司 抗病毒化合物
RU2541571C2 (ru) * 2009-04-15 2015-02-20 Эббви Инк. Противовирусные соединения
WO2014060381A1 (de) 2012-10-18 2014-04-24 Bayer Cropscience Ag Heterocyclische verbindungen als schädlingsbekämpfungsmittel
EP2914587A1 (de) 2012-10-31 2015-09-09 Bayer CropScience AG Neue heterocylische verbindungen als schädlingsbekämpfungsmittel
CN104370732B (zh) * 2014-01-26 2015-08-19 山东信立泰药业有限公司 一种氯吡格雷及其中间体的制备方法
CN109535405B (zh) * 2017-09-21 2021-07-30 宁波聚嘉新材料科技有限公司 一种基于2-(4-羧基苯基)-5-羟基吡啶并咪唑的聚芳酯的制备方法
CN109810085B (zh) * 2019-04-19 2019-07-19 上海皓元生物医药科技有限公司 Acc抑制剂及其中间体的制备方法
CN110746450A (zh) * 2019-09-17 2020-02-04 济南康和医药科技有限公司 一种贝前列素钠关键中间体的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4096264A (en) * 1975-12-09 1978-06-20 Merck & Co., Inc. Certain substituted imidazo [1,2-a] pyridines
US4250174A (en) * 1979-05-02 1981-02-10 Merck & Co., Inc. 3-Substituted imidazo [1,2-A] pyridines
US5693661A (en) * 1995-06-07 1997-12-02 Eli Lilly And Company Anti-viral compounds
US5891874A (en) * 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
BR9709528A (pt) * 1996-06-05 1999-08-10 Lilly Co Eli Compostos antivirais
US5821242A (en) * 1996-06-06 1998-10-13 Eli Lilly And Company Anti-viral compounds

Also Published As

Publication number Publication date
JP2002515433A (ja) 2002-05-28
CA2332403A1 (en) 1999-11-25
NO20005795D0 (no) 2000-11-16
EP1077701A4 (en) 2002-03-20
SK17482000A3 (sk) 2005-03-04
TR200003414T2 (tr) 2001-03-21
EA200001208A1 (ru) 2001-06-25
CZ20004278A3 (en) 2001-05-16
HUP0102117A2 (hu) 2001-12-28
AU7583098A (en) 1999-12-06
IL139166A0 (en) 2001-11-25
CN1292697A (zh) 2001-04-25
EP1077701A1 (en) 2001-02-28
WO1999059587A1 (en) 1999-11-25
NO20005795L (no) 2001-01-18
CZ289425B6 (cs) 2002-01-16
KR20010025055A (ko) 2001-03-26

Similar Documents

Publication Publication Date Title
BR9815899A (pt) Compostos antivirais
BR0113628A (pt) 7-oxo-piridopirimidinas como inibidores de uma proliferação celular
AP1753A (en) Thiophene derivatives as antiviral agents for flavvivirus infection
PL314136A1 (en) Some condensed pyrrole carboxylanilides, novel class of cerebral receptor gaba ligands
BR0014133A (pt) Uso de um composto, composto, métodos de preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
DK1105393T3 (da) Bicykliske piperidin- og piperazinforbindelser med 5-HT6-receptoraffinitet
DK1353911T3 (da) Antivirale midler
DK2097434T3 (da) Nukleosidarylphosphoramidater og deres anvendelse som antivirale midler til behandlingen af hepatitis C virus
NO20072689L (no) Tetrasykliske indolderivater som antivirale midler
WO2006027628A3 (en) Naphthalimide derivatives as antiviral agents
ATE316531T1 (de) Kondensierte dihydrochinolinon-derivate zur hemmung von mrp1
ATE277062T1 (de) Neue makrolidderivate
DK26289A (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
BR0102377A (pt) Inibidores de não-nucleosìdeo transcriptase reversa
DE69329084D1 (de) Benzoxazepin-Derivate als Cholinesterase-Inhibitoren
ATE172749T1 (de) Waschmittelzusammensetzungen zur verhinderung der farbstoffübertragung
ATE274495T1 (de) 4-hydroxy-4-phenylpiperidine-derivate mit opioid agonistischer aktivität und diese enthaltende pharmazeutika
NO20013085L (no) Fosfororganiske forbindelser og deres anvendelse
BR0016937A (pt) Compostos tricìclicos e método de tratar herpesvìrus
BR9814987A (pt) &#34;oximas substituìdas como antagonistas da neurocinina&#34;
ATE271542T1 (de) 2-thiocarbamoyloxy- und 2-carbamoyloxy-derivate von cyclopentyl-heptan(en)säure als therapeutische mittel
WO2003013499A3 (en) Drugs for vasculopaties
PT944618E (pt) Novos compostos de n-benzenossulfonilo-1-prolina processo de preparacao e utilizacao em terapia
PT1140925E (pt) 3,4-di-hidro-2h-benzo¬1,4|oxazinil-metil-¬3-(1h-indol-3il)-alquil|-aminas
DK1025101T3 (da) Naphtho-imidazo[1,2-a]pyridinderivater, deres fremstilling og deres anvendelse ved behandlingen af sygdomme i centralnervesystemet

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A,7A,8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1890 DE 27/03/2007.